-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTELLAS DOSES FIRST PATIENT IN PHASE 3 STUDY OF ASP2138 IN CLDN18.2-POSTIVE AND HER2-NEGATIVE LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA

Reuters·08/24/2026 23:30:00

Please log in to view news